Article

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

2020-10-28

Abstract excerpt

<p>After a two-decade hiatus in which research on psychedelics was essentially halted, placebo-controlled clinical trials of psychedelic-assisted therapy for mental health conditions have begun to be published. We identified nine randomized, placebo-controlled clinical trials of psychedelic-assisted therapy published since 1994. Studies examined psilocybin, LSD (lysergic acid diethylamide), ayahuasca (which contai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 47272236-8336-5cbe-aff6-07c2a4bc1463
DOI: 10.31234/osf.io/nhbjk

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted TherapyDOI 10.31234/osf.io/nhbjkRead

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted TherapySemantic proximity Read

MDMA-Assisted Therapy Randomized Controlled Trial Incremental Effects Systematic Review and Meta-AnalysisSemantic proximity Read

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part IV. PsilocybinSemantic proximity Read

Blinding and Expectancy Confounds in Psychedelic Randomised Controlled TrialsSemantic proximity Read

Commentary on methods for addressing functional unblinding and mechanistic uncertainty in clinical trials of psychedelic-assisted treatmentsSemantic proximity Read

Commentary on methods for addressing functional unblinding and mechanistic uncertainty in clinical trials of psychedelic-assisted treatmentsSemantic proximity Read

Systematic review of randomized clinical trials testing a pharmacological treatment in adults with autism spectrum disorderSemantic proximity Read

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Verify the Efficacy and Safety of Ansofaxine (LY03005) for Major Depressive DisorderSemantic proximity Read

Psychedelic Therapy: A Primer for Primary Care Clinicians – Part III. N,N-dimethyltryptamine (DMT) and AyahuascaSemantic proximity Read

Psychedelic Therapy: A Primer for Primary Care Clinicians—MescalineSemantic proximity Read

Neurodoron® in patients with neurasthenia – A randomized, double-blind, placebo-controlled clinical trialSemantic proximity Read

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): A Delphi StudySemantic proximity Read